Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine—a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays

Glenn Noronha, Kathy Barrett, Antonio Boccia, Tessa Brodhag, Jianguo Cao, Chun P. Chow, Elena Dneprovskaia, John Doukas, Richard Fine, Xianchang Gong,

Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · 22 references

DOIFull text

Open access

Concepts

References

22